相关实验视频
Updated: Jan 9, 2026
07:57
Assessing Whole-Body Lipid-Handling Capacity in Mice
Published on: November 24, 2020
4.6K
[欧洲社会委员会关于脱脂症的指导方针:2025年更新:实践的新建议]
Anna Hohneck1,2, Oliver Weingärtner3
1Klinik für Innere Medizin 1 (Endokrinologie, Diabetologie, Stoffwechselkrankheiten und Klinische Chemie), Universitätsklinikum Heidelberg, Universität Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Deutschland. annalena.hohneck@med.uni-heidelberg.de.
Herz
|December 9, 2025
概括
2025年关于失脂症的欧洲指南使用SCORE2/SCORE2-OP更新了风险评估,并引入了新的风险修饰剂. 他们强调早期的,密集的降脂,特别是急性冠状动脉综合征,并不鼓励预防补充剂.
科学领域:
- 心脏病学 心脏病学
- 动脉样硬化是一种动脉样硬化.
- 脂质代谢 脂质代谢是什么
背景情况:
- 欧洲心脏病学会 (ESC) 和欧洲动脉样硬化学会 (EAS) 定期更新失脂症指南.
- 新的证据需要对风险评估和管理策略进行修订.
研究的目的:
- 概述2025年ESC/EAS关于失脂症的指导方针中的关键创新和建议.
- 突出风险分层,风险修饰剂和治疗方法的变化.
主要方法:
- 整合更新的证据和风险评估工具,如SCORE2和SCORE2-OP.
- 包括新的风险调整因子:家族病史,种族,并发症,hs-CRP和Lp (a).
- 专注于特定的患者亚组,包括急性冠状动脉综合征,艾滋病毒和接受 antracycline 治疗的患者.
主要成果:
- 改善了心血管风险分层,特别是在老年人中,使用SCORE2和SCORE2-OP.
- 引入风险修饰剂来细化风险类别并指导治疗强度.
- 强调急性冠状动脉综合征的立即高强度他类药物治疗,通常与ezetimibe一起.
- 针对高脂蛋白[Lp[a]和高风险小组的具体建议,如艾滋病毒患者和服用大环素的人.
- 不鼓励饮食补充剂和维生素用于初级预防.
结论:
- 2025年指南加强了风险适应的低密度脂蛋白胆固醇 (LDL-C) 目标和逐步治疗.
- 扩大治疗选择和强调早期,持续的降脂是关键.
- 更新提供了基于最新的科学证据来管理脱脂症的实际建议.
相关概念视频
01:26Atherosclerosis III: Management
293
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
293
01:18Lipids: Dietary Sources and Requirements
1.8K
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
1.8K
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.3K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
534
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
534
01:26Coronary Artery Disease IV: Preventive Measures
572
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
572
01:26Angina IV: Management
215
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
215